Eagle Global Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-62,000
Closed -$425K 250
2017
Q3
$425K Hold
62,000
0.01% 190
2017
Q2
$408K Hold
62,000
0.01% 245
2017
Q1
$496K Buy
62,000
+30,000
+94% +$253K 0.01% 220
2016
Q4
$298K Hold
32,000
0.01% 275
2016
Q3
$339K Sell
32,000
-13,000
-29% -$129K 0.01% 253
2016
Q2
$420K Hold
45,000
0.01% 217
2016
Q1
$468K Buy
45,000
+9,000
+25% +$82.2K 0.02% 211
2015
Q4
$362K Buy
+36,000
New +$361K 0.01% 247
2015
Q3
Sell
-14,000
Closed -$225K 395
2015
Q2
$225K Sell
14,000
-11,000
-44% -$171K 0.01% 320
2015
Q1
$354K Sell
25,000
-14,000
-36% -$182K 0.01% 235
2014
Q4
$390K Hold
39,000
0.01% 228
2014
Q3
$332K Hold
39,000
0.01% 239
2014
Q2
$345K Buy
39,000
+5,000
+15% +$43.7K 0.01% 217
2014
Q1
$317K Buy
+34,000
New +$298K 0.01% 213

Other funds holding OPK

Eagle Global Advisors's OPK Position: Q4 2017 in Review

Eagle Global Advisors sold out of Opko Health (OPK) in Q4 2017, closing a stake of 62,000 shares — an estimated $425K sold.

Eagle Global Advisors first reported a position in OPK in Q1 2014 and held it in 14 quarters. The position peaked at $496K in Q1 2017. 231 funds tracked by Wall St. Rank hold OPK as of Q4 2017.

  • Eagle Global Advisors reported no remaining Opko Health position as of Q4 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 62,000 Opko Health shares in Q4 2017, an estimated $425K.
  • Eagle Global Advisors first reported a position in Opko Health in Q1 2014 and held it in 14 quarters.
  • Eagle Global Advisors's Opko Health position peaked at $496K in Q1 2017.
  • 231 funds tracked by Wall St. Rank held Opko Health as of Q4 2017.

Based on Eagle Global Advisors's 13F filing for Q4 2017, filed 13 Feb 2018.